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Chapter 68: The Use of Experimental Therapies in
Emergency Care
Michelle J. Mandel
Code Sections Affected
Health and Safety Code § 24177.5 (new and repealed).
SB 160 (Watson); 1997 STAT. Ch. 68
A patient arrives at a hospital emergency room with severe head injuries.
Immediately the emergency room staff tries to reduce the pressure on the patient's
brain.1 The treatment does not work and the patient dies. Now imagine that the
patient would have had a better chance of survival if the emergency room doctor
had been able to use a new experimental therapy.
2
Critically ill patients are often denied new experimental treatments because they
are unable to provide the necessary "informed consent" 3 to participate in clinical
trials and experimental therapies which may benefit them.4
I. INTRODUCTION
The doctrine of informed consent requires a doctor to inform the patient of the
risks and benefits of the proposed medical treatment and any alternative courses of
treatment. The failure of the doctor to obtain the proper consent results in battery.'
1. See Lynn Marek, Ethical Dilemma in the ER: Experiment on Patients?, CHI. Tam., May 23, 1994, at I
(stating that reducing pressure on the brain is a commonly accepted treatment for patient's suffering from severe
head injuries).
2. See id. (reporting that Dr. John Barrett, director of Cook County Hospital's trauma unit, is unable to use
a promising new treatment on patients suffering from severe head injuries because of the inablitity to obtain
informed consent and because of potential liability issues).
3. See CAL. HEALTH & SAFETY CODE § 24173 (West 1990) (stating that the patient must be given an
explanation of the proposed medical treatment and the potential benefits and risks of the procedure so that the
patient can make an informed decision); see also Arato v. Avedon, 5 Cal. 4th 1172, 1183, 858 P.2d 598, 604, 23
Cal. Rptr. 2d 131, 137 n.5 (1993) (noting that the phrase "informed consent" is often thought to have been coined
by Justice Bray in Salgo v. Leland Stanford Jr. Univ. Bd. of Trustees); see also Salgo v. Leland Stanford Jr. Univ.
Bd. of Trustees, 154 Cal. App. 2d 560, 578, 317 P.2d 170, 181 (1957) (holding that a physician violates his duty
to his patient if he fails to disclose any information which is necessary for the patient to make an informed
decision).
4. See Richard S. Hamburg, Public Policy Solutions Sought for Emergency Care, 10 J. CARDIOVASCULAR
NURSING 85, 85 (1996) (stating that patients in life-threatening situations are often denied new treatments because
they are unable to provide "informed consent").
5. See CAL. HEALTH&SAFE CoDE§24175 (West 1990) (establishing the informed consent doctrine that
requires a medical professional to advise the patient of the risks, benefits, and alternatives to the proposed
treatment); see also Luka v. Lowrie, 136 N.W. 1106, 1110 (Mich. 1912) (holding that a physician is justified in
treating a patient in an emergency situation, and a surgeon may lawfully perform a potentially life-saving operation
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Although there is a recognized emergency exception to the doctrine of informed
consent, 7 it is unclear whether the use of experimental therapies falls within this
exception.8
The emergency exception exists because, in a life-threatening situation, the
patient's right to know of the risks, benefits and alternatives of the proposed medi-
cal treatment is supplanted by the gravity of the situation.9 Chapter 68 places the use
of experimental therapies within the emergency exception under a narrow set of
conditions. °
Chapter 68 relaxes the informed consent doctrine to conform with recent Food
and Drug Administration (FDA) regulations and to allow doctors to administer
investigational therapies where theirpatients are in life-threatening situations. "The
American Association of Critical Care Nurses supports Chapter 68 because they
believe that a patient in a life-threatening situation should not be denied a promising
investigational therapy.1 2 Also, they assert that Chapter 68 conforms with federal
regulations that require extensive studies of investigatory procedures before they
are administered on patients. In addition, the hospital Institutional Review Boards
without the patient's consent).
6. CAL HEALTH & SAFETY CODE § 24178(a) (West 1990) (setting forth penalties for the person who
negligently allows or performs medical treatment conducted without informed consent).
7. See CAL. Bus. & PROF. CODE § 2397 (West 1990) (declaring that a licensee is not liable for civil
damages for injury or death caused by an emergency situation in which the patient has not provided informed
consent). The rationale is that a patient is unable to give his informed consent when he is facing a life-threatening
situation. In eddition, in an emergency situation it is not feasible to try to contact the patient's legal representative
to obtain their consent, because of the time constraints. Id. § 2397; see also Halle Fine Terrion, Informed Choice:
Physicians' Duty to Disclose Nonreadily Available Alternatives, 43 CASE W. RES. L. REV. 491, 506-07 (1993)
(explaining that the term "emergency" is ambiguous). Some commentators think that the emergency exception to
the informed consent doctrine should only apply when the patient is unconscious, and that the harm that would
result from nontreatment overrides the risk involved from the medical treatment. Another author suggests that the
emergency exception should apply when the patient is unable to give his consent to receive information. Id. 507.
8. See Richard S. Saver, Critical Care Research and Infonned Consent, 75 N.C. L. REV. 205, 231 (1996)
(explaining the ambiguities of the informed consent doctrine); see also Richard Delgado and Helen Leskovac,
Informed Consent in Human Experimentation: Bridging the Gap Between Ethical Thought and Current Practice,
34 UCLk L. REV. 67, 67-68 n.1 (1986) (stating that unorthodox therapies are often controversial even when
patients are in a life-threatening situation, or the doctor administers the therapy as a last resort).
9. See Terrion, supra note 7, at 506 (explaining that a physician's inability to obtain informed consent from
their patient often prevents lives from being saved).
10. CAL. HEALTH & SAFETY CODE § 24177.5 (enacted by Chapter 68); see SENATE JUDICIARY COMMrTTEE,
COMMtrE ANALYSIS OF SB 160, at 2 (Mar. 11, 1997) (stating that Chapter 68 provides an exception to the
Protection of Human Subjects in Medical Experimentation Act when a person is in a life-threatening situation and
is unable to give informed consent). In addition, a number of safeguards have been included in the law to protect
the patient's rights, including a requirement that valid scientific studies must be conducted on the experimental
therapy lefore administering the proposed medical treatment. Id.
11. CAL HEALTH & SAFETYCODE § 24177.5 (enacted by Chapter 68); see SENATEJUDICIARY COMMtrEE,
COmxrrmE ANALYSIS OF SB 160, at 3 (Mar. 11, 1997) (acknowledging that proponents of Chapter 68 argue that
this law is needed to bring California law into conformity with federal regulations).
12. See SENATE JUDICIARYCOMMirrE, COsMrrrEEANALYSIS OFSB 160, at 3 (Mar. 11, 1997) (explaining
that, as an organization which represents 76,000 critical care nurses, the members are familiar with situations in
which lives are lost because investigational procedures were not used).
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(IRBs) retain the power to approve or stop the proposed treatment from being
implemented. 3 The proponents of Chapter 68 assert that the narrowly drafted
exception protects patients' rights while at the same time increasing the ability of
doctors to administer experimental therapies which may save a greater number of
lives.14
However, Chapter 68 poses constitutional and ethical problems. Free will, an
individual's autonomy, and respect for bodily integrity all underlie the doctrine of
informed consent.1 5 There is a tension between respecting and valuing an
individual's personal autonomy and the need to advance emergency medical pro-
cedures and technologies.'
6
I. LEGAL BACKGROUND
An individual's right to make choices affecting what happens to his body is a
highly valued principle in our society.17 The law has evolved to reflect this
principle. After World War II, there was an increasing awareness of the negative
impacts thathuman experimentation could have on society."8 In the 1970s, measures
were taken to further protect patients rights against experimentation.19 In response
to the public's outrage at the discovery that patient's rights were being violated in
order to conduct medical research,20 Congress enacted the National Research Act
13. Id.; see Saver, supra note 8, at 215 (defining an Institutional Review Board (IRB) as a committee
established to approve applications for individual investigations at different research institutions).
14. SENATE JUDICIARY COMMITTEE, COMMITrEE ANALYSIS OF SB 160, at 3 (Mar. 11, 1997).
15. See Saver, supra note 8, at 237 (recognizing that the value we place on an individual's autonomy
presents the most serious barrier to relaxing the informed consent doctrine in life-threatening situations).
16. See Marek, supra note 1, at l(reporting that doctors all over the country face the delicate balance
between the need to advance emergency medical procedures without violating the rights of a patient who are unable
to give their informed consent); see also Jay Katz, Human Experimentation and Human Rights, 38 ST. LOUIS LJ.
7, 7 (1993) (explaining that there is a conflict between a doctor's duty to care for and treat his patient and the
doctor's dedication to engage in research in the hopes of advancing medical knowledge); John Schwartz, Rules
Eased for Emergency Therapy, Some Experimental Devices to Be Used Without Patient's Consent, WASH. POST,
Sept. 27, 1996, at All (observing that emergency care research is one of the most difficult balancing acts in
medicine).
17. See Union Pac. Ry. v. Botsford, 141 U.S. 250,251 (1891) (stating that "[n]o right is held more sacred,
or is more carefully guarded, by the common law, than the right of every individual to the possession and control
of his own person free from all restraint or interference of others.. ."); see also Sharon N. Perley, From Control
Over One's Body to Control Over One's Body Parts: Extending the Doctrine of Informed Consent, 67 N.Y.U. L.
REV. 335,336-37 (1992) (addressing the importance of an individual's right to control what happens to theirbody).
18. See Katz, supra note 16, at 8 n.3 (explaining that the increased awareness of the horrors of the medical
experiments conducted by the doctors in the concentration camps, and the revelation of the Tuskegee Syphilis Study
conducted by Public Health Service doctors in the United States between 1932-1972, reinforced the necessity for
regulations that would protect the subjects of research).
19. See Saver, supra note 8, at 215 (detailing the legal background for the regulations of medical
experimentation).
20. See Delgado & Leskovac, supra note 8, at 68 n. I (explaining that their definition of "research" means
biomedical and behavioral treatments and practices in which the goal is to gain new scientific knowledge).
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(NRA) in 1974.21 The NRA authorized the establishment of the National Com-
mission for the Protection of Human Subjects of Biomedical and Behavioral
Research, which issued the influential Belmont Report.22 The Belmont Report set
forth guidelines and ethical principles for the protection of human subjects in
medical research, and has influenced the enactment of federal agency regulations.23
There are four reasons why it is important to obtain individuals' informed
consent when they are the subject of a medical experiment.26 First, the risks and
side-effects of experimentation cannot be known in advance.27 Second, there are no
experts in the field of medical experimentation. 2' Third, experimentation usually
provides the subject with few benefits.29 Finally, the interests of the researcher and
the subject are often in conflict.30 Yet, the recent trend is to relax some of these laws
with the hope of saving more lives while advancing medical research."'
A. Existing Law
Prior to the enactment of Chapter 68, existing law required that physicians
obtain informed consent before conducting any experimental medical procedures
on human beings.32 In addition, although existing law included an emergency
exception to the informed consent doctrine, it did not allow the administration of
potentially beneficial experimental therapies to patients in life-threatening
situations.3
21. Id. at 68; National Research Act of 1974, Pub. L. No 93-348, 88 Stat. 342 (codified by 42 U.S.C.A. §
241 (1994)).
22. See Saver, supra note 8, at 215 (providing background on the increase of legislation dealing with
patient's rights).
23. See id. (recognizing the influence of the Belmont Report on the Food and Drug Administration and
Health and Human Services revisions of their regulations).
26. See Delgado & Leskovac, supra note 8, at 87 (explaining that courts and scholars have provided us with
four reasons why our society should protect subjects of human experimentation).
27. See id. (explaining that the outcomes of experimental procedures and treatments are uncertain and oftLn
pose high risks).
28. See id. at 89 (explaining that because the researcher is uncertain of the outcome of the experiment, he
offers no greater expertise to help the patient decide what to do with his body).
29. See id. at 90 (stating that medical treatment is meant to help a patient; whereas the purpose of medical
experimentation is to aid people in the future).
30. Il at91.
31. See ASSEMIBLYCOMMITEEONHEALTH, COMMrTEEANALYSIS OFSB 160, at 2 (June 17, 1997) (stating
that the purpose of Chapter 68 is to improve the care of patients in life-threatening situations).
32. CAL. HEALTH & SAFETY CODE § 24172 (West 1992); see SENATE JUDICIARY COMMITTEE, COMMITFEX
ANALysis OF SB 160, at 2 (Mar. 18, 1997) (explaining that existing law did not provide a qualified immunity to
the informed consent doctrine making it easier for doctors to administer investigational therapies in life-threatening
situations).
33. See CAL. HEALTH & SAFETY CODE §§ 24173, 24175 (West 1992) (propounding an informed consent
doctrine which requires advising a patient of the procedures, risks, benefits and alternatives, and the right to decline
consent); see also id. §§ 26678,26679 (West 1992) (relating to the use of experimental drugs); see also Review of
Selected 1978 Califomia Legislation, 10 PAC. L.J. 510, 510 (1979) (providing legislative intent relating to the
informed consent doctrine).
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Prior to the enactment of Chapter 68, there had been a trend to relax the
doctrine of informed consent on the federal level. 4 Recent FDA and National
Institute of Health (NIH) regulations waive the informed consent requirement in
life-threatening situations.35 The FDA measures were introduced to help people in
critical care who may benefit from experimental treatments but are unable to give
their informed consent.36 Under the new FDA regulations, a doctor may rely on
implied consent where the patient will die without intervention.37
The FDA regulations, issued on October 2, 1996, stem from a need to advance
medical research and save a greater number of lives.38 The FDA regulations are an
attempt to remove the barriers hindering critical research in a limited number of
situations, while protecting the patient's rights.39
B. Chapter 68
Chapter 68 expands the ability of medical professionals to develop, analyze,
and refine investigational therapies for the treatment of patients in life-threatening
34. See 21 C.F.R. §§ 50.23, 50.24 (1997) (setting forth an emergency exception to the informed consent
doctrine which allows consent to be waived under a narrow set of conditions).
35. See Saver, supra note 8. at 249 (noting that FDA regulations permit informed consent to be waived
where: (1) The patient is in a life-threatening situation; (2) available treatments are unproven or unsatisfactory; (3)
the patient is unable to consent because of their medical condition; (4) intervention must be administered before
consent can be obtained from a legal representative; and (5) the risk of intervention is reasonable in light of what
is known about the medical condition, current treatment, and the proposed treatment).
36. See Baruch A. Brody, New Perspectives on Emergency Room Research; Change in Informed Consent
Laws; In Case of Emergency: No Need for Consent, THE HASTINGS CENTER REP., Jan. 11, 1997, at 7 (identifying
four reasons for the new FDA regulations: (1) The social need for research in emergency settings; (2) the potential
benefit to patients of promising new therapies; (3) the need to keep strict controls on the administration of
experimental therapies in order to prevent the abuse of patient's rights; and (4) the need to safeguard patients from
experimental therapies that turn out to be harmful); see also FDA, NIH Ease Rules on Experiments in Emergencies,
PUB. HEALTH REP., JanJFeb. 1997, at 6 (observing that the new FDA rules make it easier for doctors to use
promising experimental drugs on patients facing life-threatening situations who because of their medical condition,
are unable to give informed consent).
37. See ASSEMBLY COMMrrrEE ON HEALTH, COMMrITEE ANALYSIS OF SB 160, at 2 (Mar. 18, 1997).
38. See John Schwartz, Rules Eased for Emergency Therapy; Some Experimental Devices to Be Used
Without Patient's Consent, WASH. POST, Sept. 27, 1997, at AI I (stating that the FDA regulations protect patients
who may be saved by an investigational procedure); see also Saver, supra note 8, at 206-207 (commenting that
approximately 350,000 people suffer from heart attacks each year, and the majority of them die). There is a question
whether accepted and standard CPR techniques are adequate. A new CPR device has been created called the
"cardiopump," and it has potentially promising benefits. Yet, the FDA stopped the "cardiopump" clinical trials
because doctors were unable to obtain the required consent from their patients. This is an example of a situation
in which a device may prove to save lives, but it cannot be used because of the rigid informed consent rules. The
new FDA regulations are designed to make it easier to use experimental therapies such as the "cardiopump" in life-
threatening situations.
39. See Schwartz, supra note 16, at All (reporting the tension between people's fear of being used in
experiments because of abuses in the past, and the need for new therapies which will benefit society).
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situations.40 Chapter 68 is designed to allow critically ill or injured people to have
access to life-saving therapies when informed consent cannot be obtained.
Chapter 68 amends existing law to allow the use of experimental therapies on
patients in life-threatening situations who are unable to give their informed
consent.4 2 This exception to the Human Subjects in Medical Experimentation Act
has been narrowly drafted to apply in limited situations in order to protect the
bodily integrity of the patient.
43
Im. CONSTITUTIONAL AND ETHICAL ISSUES
The constitutional right to control medical decisions is still evolving in medical
jurisprudence and is a highly debated issue among legal scholars.4 Western ethics
place a high value on the principle of individual autonomy. Indeed, individual
autonomy is a fundamental right in our society implicit in the Constitution.45 The
Supreme Court recognizes rights to bodily integrity, liberty, and self-determination
that stem from the principles set forth in the Constitution.5
The concept of personal autonomy favors the individual over the community,"
and can be traced back to the works of Western philosophers Locke and Mill.
48
40. SENATEJUDICIARYCOMMITrEE, COMMrrrEEANALYSISOFSB 160, at 3 (Mar. 1, 1997); see ASSEMBLY
COMMTEE ON HEALTH, COMMITTEE ANALYSIS OF SB 160, at 2 (June 17, 1997) (declaring that the intent of
Chapter 68 is to expand doctor's abilities to administer investigational therapies).
41. SENATEJUDICIARYCOMMrIrEE, CoMMrrEEANALYSISOFSB 160, at2 (Mar. 11, 1997); see ASSEMBLY
COMMITrEE ON HEALTH, COMMITEE ANALYSIS OF SB 160, at 2 (June 17, 1997) (explaining that Chapter 68
provides an exception to the requirements of the Protection of Human Subjects in Medical Experimentation Act
for the treatment of a patient in a life-threatening situation).
42. See CAL HEALTH & SAFETY CODE § 24177.5 (enacted by Chapter 68).
43. See id. (permitting the exception when the following conditions are met: (1) The patient is in a life-
threatening situation; (2) the patient is unable to give informed consent; (3) obtaining informed consent from a legal
representative is not feasible because of time constraints; and (4) valid scientific studies have been conducted that
support the potential for the intervention to provide a direct benefit to the patient).
44. Saver, supra note 8, at 232.
45. See Elysa Gordon, Multiculturalism in Medical Decisionmaking: The Notion of lnformed Waiver, 23
FORDHAMURB. LJ. 1321, 1321 (1996) (providing a history of the ideals of autonomy and the doctrine of informed
consent according to Western principles).
46. See U.S. CO NST. amend. XIV (stating that no State shall deprive any person of life, liberty, or property
without due process of law); see also Roe v. Wade, 410 U.S. 113, 152 (1973) (finding that a woman's right to have
an abortion is based upon the constitutional right to bodily privacy).
47. See Gordon, supra note 45, at 1325 (explaining the importance American society places on the
individual and the principles of privacy and self-determination); id. at 1343 (stating that the emphasis on the
individual in our society has influenced laws which provide for patient autonomy).
48. See JOHN LOCKE, Two TREATISES OF GOVERNMENT 283 (Cambridge Univ. Press 1988) (writing that
"the natural liberty of man is to be free from any superior power on earth and not to be under the will or legislative
authority of man, but to have only the law of nature for his rule"); see also JOHN STUART MILL, ON LIBERTY (E.
Rapaport ed., 1978).
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These Western philosophers influenced American jurisprudence, and their ideals
and theories are embodied in the Constitution.49
The concept of patient autonomy emerged as a response to the civil rights
movement in the 1960s.50 Yet, it can also be seen in the early 1900s in the case of
Schloendorffv. Soc'y of New York Hosp.,5' which held that a patient has a right to
make decisions concerning his body except in the case of an emergency when the
patient is unconscious and is unable to give informed consent.52 In 1972, the Ameri-
can Hospital Association issued A Patient's Bill of Rights to convey the importance
of patient autonomy.
53
Informed consent initially developed as a safeguard to unauthorized touching,
but it has been extended by the courts.' The doctrine of informed consent embraces
the ideas of autonomy, liberty, and privacy,"' and stems from a patient's right to
make decisions regarding his own body.5 6 The problem the medical community
faces is how to advance emergency medical treatments without violating a patient's
autonomy. 7 Can we justify the waiver of informed consent if it will save a person's
49. See Gordon, supra note 45, at 1327 (stating that the concept ofpersonal autonomy is a fundamental right
which is supported by the right to bodily integrity, liberty and self determination which is interpreted by the courts
to be in the Constitution).
50. Gordon, supra note 45, at 1327.
51. 105N.E. 92, 93-94, 211 N.Y. 125,129-30 (N.Y. 1914).
52. Id.
53. See Nancy E. Brazell, The Significance and Application ofInformed Consent, 65 ASS'N OPERATING
RooM NuRsEs J. 377,377 (1997) (noting that the Patient's Bill of Rights includes statements that declare that a
patient has a right to receive information regarding the risks, benefits and prognoses of the proposed treatment).
54. See Mohr v. Williams, 104 N.W. 12, 15 (Minn. 1905) (holding that patients have the right to weigh the
risks and benefits of the proposed medical treatment); see also Pratt v. Davis, 79 N.E. 562, 564 (11. 1906) (holding
that a physician should be required to obtain a patient's informed consent before performing surgery if the patient
is conscious and is in good mental health); see generally Cobbs v. Grant, 8 Cal. 3d 229, 242, 502 P.2d 1, 9, 104
Cal. Rptr. 505, 513 (1972) (enunciating four postulates related to the doctrine of informed consent: (1) Patients
generally do not have the same knowledge as their physician; (2) competent adults have a right to make decisions
with regard to their bodies; (3) patient consent must be an informed consent; and (4) patient puts trust in a physician
because they have training and knowledge in the medical field).
55. Gordon, supra note 45, at 1327.
56. See Schloendorff, 105 N.E. at 129 (stating that "every human being of adult years and sound mind has
a right to determine what shall be done with his own body; and a surgeon who performs an operation without his
patient's consent, commits an assault"); see also Gordon, supra note 45, at 1328 (explaining that informed consent
emphasizes the right of an individual to make decisions that affect their body). The doctrine of informed consent
embodies four principles: (1) Emphasizes the right of an individual to make decisions regarding medical treatment;
(2) encourages physicians to be forthright regarding the proposed treatment, risks, benefits and prognosis; (3)
stresses secularism over spirituality; and (4) emphasizes the participation of an individual in medical decision
making. Id.
57. See Saver, supra note 8, at 233 (acknowledging that there may be constitutional limits placed on
attempts to relax or reform the informed consent doctrine, and that the right to privacy regarding medical treatment
may be infringed by changes in the informed consent doctrine); see also Peter H. Schuk, Rethinking Informed Con-
sent, 103 YALELJ. 899,924 (1994) (commenting on the fact that the principle of autonomy is deeply rooted in our
society).
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life? Can we reasonably assume that a patient would consent to an experimental
therapy? 8
One alternative is eliminating the informed consent doctrine altogether in
critical care situations.5 9 The argument behind this proposal is that the medical
community is ethically bound to do what is best for the patient, and if the doctor
believes that he will have greater success saving the patient's life by administrating
an experimental therapy, then he should be able to do so?° The downside to imple-
menting this alternative is that it opens the door to abuse t.6
Another alternative is deferred consent in which a patient or patient's repre-
sentative is told of the risks and benefits as soon as possible after the treatment has
been administered.62 At this point, the patient or his representative can withdraw or
decline further treatment. 3 Another alternative is to seek consent from potential
patients before they are in a life-threatening situation6 4 The variety of alternatives
signifies the conflict in the medical community between protecting a patient's auto-
nomy and advancing medical research.
One of the main purposes of Chapter 68 is to improve the care of patients in
life-threatening situations.65 A person who enters an emergency room unconscious
or suffering from a cardiac arrest or a stroke is not in a position to weigh the risks
and benefits of the proposed medical treatment. 6 Time is of the essence; and, if the
person's life is to be saved, it is important for the physician to have the authori-
zation to act immediately in the best interest of the patient. The administration of
an experimental therapy or drug may have a greater chance of saving a person's life
58. See Saver, supra note 8, at 231 (remarking that when the proposed treatment is experimental it is
difficult to ascertain whether a reasonable person in the same circumstances would choose the experimental therapy
over the standard treatment).
59. Jd. at241.
60. Id. at 241.
61. Id.; see Marek, supra note 1, at 2 (illustrating examples of' abuse in the use of experimental therapies).
For example, in Minnesota a hospital research review board permitted a cardiac resuscitation device to be tested
on young children even though the device was intended for adults. Id. See generally MARY SHELLEY, FRANKEN-
STEIN (Bamtam Books 1997) (1818) (illustrating a fabled example of a medical experiment that went awry).
62. See Saver, supra note 8. at 244 (explaining that under this approach the experimental therapy is used
without obtaining informed consent, but as soon as the patient regains consciousness or the patient's legal
representative is available, they are told of the procedure and have the option of withdrawing from the treatment).
63. Id.
64. See id. (commenting that, in theory high risk patients could be identified and contacted to seek their in-
formed consent in the case that they are in a life-threatening situation and are unable to make decisions because of
their medical condition).
65. CAL. HEALTH & SAFETY CODE § 24177.5(2) (enacted by Chapter 68); see ASSF2,IBLY COMMITTEE Oi
HEALTH, COMMITTEEANALYSIS OFSB 160, at 2 (June 17, 1997) (stating that the Society of Critical Care Medicine
asserts that without the passage of this bill, patients in emergency situations who might be saved by an
investigational therapy will probably die).
66. See ASSEMBLYCOMMITTEEONHEALTH, CoMMITTEEANALYSISOFSB 160. at 2 (June 17, 1997) (stating
that the California Health Care Association (CHCA) asserts that communication between a physician and his patient
is difficult or impossible if the patient is facing a life-threatening situation).
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than a standard therapy that does not have proven success. 67 Chapter 68 was not
established to compromise bodily integrity, autonomy or privacy; it was established
to help save a greater number of lives.
IV. CONCLUSION
In order to improve the care of critically ill patients, the government needs to
relax the rigidity of the informed consent doctrine while protecting an individual
from abuse in the name of medical research.68 Chapter 68 and the FDA regulations
are a step toward making it easier for medical professionals to use promising new
therapies that may increase the number of lives saved of people suffering from
strokes, comas, severe head injuries, and heart attacks where there are no proven
satisfactory medical treatments. 69 At the same time, however, these provisions are
narrowly tailored to ensure effective protection of the critically ill patient's personal
autonomy.70 In this way, advances in necessary medical research are possible
without jeopardizing valuable patient rights.
67. See CAL. HEALTH & SAFETY CODE § 24177.5(6) (enacted by Chapter 68) (requiring that valid scientific
studies of the experimental therapy be conducted to show that the administration of the therapy will be potentially
beneficial to the patient).
68. See Saver, supra note 8, at 239 (acknowledging that inflexible rules can interfere with principles of
beneficence and justice).
69. See Terence Bums, M.D., CPRAdvances Stymied by Informed Consent, BUFFALO NEWS, Nov. 30, 1994,
at 3 (declaring that if the doctrine of informed consent is not relaxed then the "treatment of cardiac arrest in 2000
will be the same as in 1994, with no advances, no progress and no improvement in survival rates").
70. See supra note 43 and accompanying text (discussing the narrow requirements for consent to be waived
in emergency situations).
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Successful Animal Cloning Raises Questions About Human
Cloning Possibilities: Science Fiction No Longer
Erin M. Stepno
Code Sections Affected
Business and Professions Code §§ 2260.5, 16004,16105 (added and repealed).
SB 1344 (Johnston); 1997 STAT. Ch. 688
Health and Safety Code §§ 24185, 24187, 24189 (added and repealed).
SB 1344 (Johnston); 1997 STAT. Ch. 688
I. INTRODUCTION
[Llike the splitting of the atom, this is a discovery that carries burdens as
well as benefits.
-President Bill Clinton'
In the February 27, 1997, issue of the science journal Nature, Dr. Ian Wilmut
and his colleagues at the Roslin Institute in Edinburgh, Scotland, reported to the
world that their laboratory had successfully cloned a sheep from an udder cell of an
adult ewe. The cloned sheep, known as "Dolly," triggered a worldwide debate as
to the ethical, legal, moral, and religious implications surrounding the scientific
breakthrough. Immediately, President Bill Clinton, on March 4, 1997, banned the
use of federal monies for human cloning research and requested that the private
sector voluntarily comply with the moratorium. President Clinton also requested
that the National Bioethics Advisory Commission review the cloning situation and
report back within ninety days.4
On June 9, 1997, President Clinton accepted the recommendations of the Com-
mission and asked Congress to ban human cloning for a minimum of five years, but
also asked to allow scientists to pursue research involving recreation of human cells
1. Marlene Cimons & Jonathan Peterson. Clinton Bans U.S. Funds for Human Cloning Research, L.A.
TINES, Mar. 5, 1997, at Al.
2. Dr. Ian Wilmut et al., Viable Offspring Derived fronm Fetal and Adult Mamnalian Cells, NATURr, Feb.
27,1997, at 310.
3. See Cimons & Peterson, supra note I, at Al (indicating that President Clinton wished for the cloning
situation to be investigated further before any actual experiments take place).
4. Ellen Hale, Cloned Sheep RaisesStakes in Debate over Genetics, Ethics, GANNETrNEWS SERVICE, Feb.
24, 1997, at S 1I.
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and tissues.' Since the cloning breakthrough was reported, national leaders in many
fields have tried to propose a workable balance between the advancement of science
and the facets of life that such breakthroughs affect.6 Lawmakers have striven to
memorialize such a balance into legislation so that foreseeable problems with the
research can be avoided.7
In California, one such law has been adopted, Chapter 688, which mandates a
five year moratorium on human cloning.8 The California Legislature believes, as
does Congress, that the five year period will allow the legal, ethical, moral and
religious fields to investigate foreseeable situations that may arise in light of the
cloning breakthrough that occurred in Scotland. 9
I. WHAT IS CLONING?
The term "cloning" has, in recent years, become a part of our vernacular-
easily found in literature, news broadcasts, and radio programs. However, while
some citizens may consider "cloning" to be a procedure limited to producing many
identical humans or complete organisms, scientists generally do not consider this
to be the true use of the word."0 A biologist would define a "clone" to be a col-
lection of genetically identical organisms, cells, viruses, or DNAtt derived from the
reproduction of a virus, single cell, or DNA molecule.' 2 There are three common
types of cloning techniques: molecular cloning, cellular cloning, and nuclear trans-
plantation cloning.'
3
5. Jodi Enda & Shankar Vedantam, Clinton Asks Congress to Ban Human Cloning but Allow Research,
PHILADELPHIA INQUIRER, June 10, 1997, at A10.
6. See Senate Subcommittee on Public Health and Safety-Scientific Discoveries in Cloning: Challenges
for Public Policy (1997) (statement of Bill Frist) (describing the purpose of the Congressional hearing as investi-
gation into the public policy implications created by the cloning breakthrough); Charles Krauthammer, A Special
Report on Cloning, TIME, Mar. 10, 1997, at 60 (listing medical advancement as one major facet of life that cloning
may effect, such as insights into spinal cords, heart muscles, and brain tissues which do not regenerate after injury,
as well as the growth patterns of cancer cells).
7. See News Release from Jim Battin, Assemblyman of Eightieth District (Apr. 16, 1997) (copy on file
with the McGeorge Law Review) (stating that the cloning legislation, "[gloes strictly to prohibiting the cloning of
entire human beings and does not preclude potential beneficial uses such as regenerating spinal cord tissue for
accident victims or skin tissue for bum victims").
S. LEGISLATIVE COUNSEL'S DIGEST, ANALYSIS OF SB 1344, at 1-3 (Oct. 4, 1997).
9. SENATE COMMITTEE ON HEALTH AND HUIAN SERVICES, COMMITTEE ANALYSIS OF SB 1344, at 2-3
(Apr. 16, 1997).
10. PAUL BERG & MAXINE SINGER, DEALING wITH GENES-THE LANGUAGE OF HEREDITY 89 (University
Science Books 1992).
11. LUBERT STRYER, BIOCHEMISTRY 71 (W.H. Freeman & Co., 3d ed. 1988) (defining "DNA" as
"Deoxyribonucleic Acid which is a very long, threadlike macromolecule comprised of deoxyribonucleotides (each
comprised of a base, sugar, and phosphate group) whose bases carry genetic information and whose sugar and
phosphate groups give the molecule its characteristic double-helical structure").
12. See BERG & SINGER, supra note 10, at 89 (clarifying the distinction between what scientists consider
to be cloning and what others may perceive it as).
13. Bioethics Commission Backs Federal Human Cloning Ban Pending More Stud.ty Debate, I MEALEY'S
LITIG. REP.: BIOTECHNOLOGY 15, 16 (1997).
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The first two types of cloning do not carry the possibility of developing another
entire organism, as neither egg nor sperm cells are used, however both techniques
have other applications."4 Molecular cloning has become an invaluable way for
recombinant DNA technology to produce vital medical substances, such as insulin;
while cellular cloning has enabled scientists to grow specific cells in a culture
which results in a cell line that is identical to the original cell, an invaluable
resource in studying the nature of many medical maladies.' 5 The latter method of
cloning, nuclear transplantation cloning, is often referred to as "blastomere
separation," and is capable of producing a genetically identical child or animal.
16
It is this type of cloning that is the subject of Chapter 688.
Im. THE OCCURRENCE IN SCOTLAND
In a most simplistic description, the scientists from the Roslin Institute and PPL
Therapeutics in Midlothian, United Kingdom, successfully transferred the nucleus
1 7
from an udder cell of an adult sheep into an egg whose DNA had been removed.'
The researchers reduced the nutrient-laden serum given to the donor cells in order
for them to behave more like the inactive DNA found in an unfertilized egg or
sperm. 19 An electric current was then used to fuse the donor cell with an egg whose
chromosomes had been removed.20 That fusion gave the egg a full compliment of
new DNA and initiated the development process.2 Ironically, none of the scientists
are certain as to how the DNA from the udder cell was able to direct the develop-
ment of an entire new organism. 22 Researchers are also uncertain as to how effective
this procedure will prove in other organisms.'
14. Id.
15. Id.
16. rd.
17. See BERG & SINGER, supra note 10, at 248 (defining "nucleus" as the sac within a eukaryotic cell that
contains chromosomes).
18. Elizabeth Pennisi & Nigel Williams, Will Dolly Send in the Clones?, SCIENCE, Mar. 7, 1997, at 1415.
19. Id.
20. Id.
21. Id
22. rd
23. Id. See generally Scientists Grow Monkeys from Cloned Embryos (visited July 26, 1997) <http:l/
www.cnn.comrECH/9703/02/monkey.monkey/index.html> (describing how scientists at the Oregon Regional
Primate Research Center successfully produced two sibling rhesus monkeys using cloned embryos. These two
monkeys are not genetically identical, as cells from different embryos were used, but set the stage for producing
genetically identical animals).
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IV. SOCIETAL ISSUES THAT CLONING AFFECTS
A. The Idea of Each Human Being as a Unique Individual
If the cloning procedures that made the existence of Dolly possible are refined
to a point where the procedure is safe and effective for human beings, there would
then be the possibility of creating an infinite number of genetically identical
persons.24 Each cell of a human body contains the same genetic material, and thus
provides an infinite supply of starting material for the cloning procedure.25 If many
clones result from one person, both the original person and its clones will lack the
concept of individuality that is such an important aspect of human life. The
researchers in Scotland realized that their successfully cloned sheep may be seen
as simply a scientific commodity and in all press releases referred to the sheep as
"Dolly" to give the sheep an individual character, as opposed to "6LL3," the title
that she received in the scientific reports of which she was the subject.26 On the
other hand, it must be noted that both genetic composition and environmental
factors are what shape the existence of a human.27 Thus, like identical twins, the
clones will share genetic material, but they may manifest this material in differing
ways depending on their lifestyle and environment.
B. Choosing Traits and "Designing" Humans
Successful sexual reproduction results in an offspring that has inherited from
its parents an unpredictable mix of the traits that they themselves express or carry
within their genetic material. 28 However, with cloning one may choose as the
starting material of life a cell from a human who possess traits that they find
attractive for various reasons. 29 Such a concept brings to mind eugenic practices of
the past that strove to propagate traits that were viewed as superior.30 Opponents of
human cloning fear that if clones express only the most-beautiful attributes, then
those individuals with disabilities of any sort would be greatly discriminated against
and entirely devalued.3' In addition, some opponents fear that certain persons would
arrange it so that they could clone the most intriguing persons of the time, not only
24. Scientific Discoveries in Cloning: Challenges for Public Policy; Hearing Before the Subcomm. on
Public Health and Safety of the Senate Comm. on Labor and Human Resources, 105th Cong. (1997) (statement of
Karen Rothenberg) [hereinafter Scientific Hearings].
25. Id.
26. George J. Annas, Human Cloning: Should the United States Legislate Against It?, 83 A.B.A. J. 80, 80
(1997).
27. Id.
28. See Scientific Hearings, supra note 24 (explaining various ideas of genetic identity).
29. Robert Wachbroit, Human Cloning Isn't as Scary as It Sounds, WASH. POST, Mar. 2, 1997.
30. Id.
31. See Scientific Hearings, supra note 24 (detailing problems that may arise due to perfecting a person to
a degree not currently possible).
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to have a "child" potentially displaying such attributes, but solely for the notoriety
of having done so.
32
C. Reversal of Gender Roles, Notions of Surrogacy, and the "Family"
Dynamic
With the advent of cloning, no longer is the union of males and females neces-
sary in order to produce an offspring.3 Theoretically, only females are necessary
for the propagation of the human race, because they alone have the ability to carry
the clone to term2 4 This notion has profound consequences for the orientation of
gender roles and the idea of parental responsibility.3 5 Two possible situations exist
that may remedy such a female-dominated hypothetical situation: (1) The use of
surrogate "mothers," and (2) the development of artificial wombs. 3 6 To this day,
surrogacy, as used for non-cloning reproductive technology, is unregulated at the
federal level and only addressed in few states' legislation. 7 The creation of the
necessary artificial womb for human gestation is long from being a reality and
would present its own legal and moral debate.
In addition, as previously mentioned, the donor of the cell from whom the clone
is produced will be a genetic copy of the clone.38 This genetic "twin" fits more
closely the definition of a sibling to the cell donor, rather than its child.39 Thus, if
human cloning advances to this point the legal and psychological ramifications of
such technology will need to be addressed.
V. LEGAL ISSUES RAISED BY HUMAN CLONING
In addition to the moral and ethical concerns, there are many areas of law
greatly affected by human cloning. The law has to this point failed to sufficiently
address many scientific breakthroughs. For example, in vitro fertilization [IVF]
technology raised questions of parental identity, posthumous reproduction, and
embryo disposition that have yet to be legally settled.40 Suddenly, human cloning
32. See Wachbroit, supra note 29 (explaining one of the unlikely, yet not impossible, situations that cloning
brings aboat.
33. See Scientific Hearings, supra note 24 (discussing how cloning would affect males and females
differently).
34. Id.
35. Id.
36. I.
37. Id.
38. Cloning-Challenges for Public Policy: Hearings Before the Subcomm. on Public Health and Safety
of the Senate Labor and Human Resources Comnm., 105th Cong. (1997) (statement of Alta Charo, J.D., member
of the National Bioethics Advisory Commission) [hereinafter Cloning Challenges Hearings].
39. Id.
40. Annas, supra note 26, at 80.
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has surfaced and lawmakers seek to avoid the pattern of history and address fore-
seeable situations that this breakthrough presents.
A. Is the Ban on Cloning Constitutional?
As mentioned previously, President Bill Clinton banned the use of federal
monies for human cloning on March 4, 1997, in light of the Dolly controversy.
Ironically, according to the British Science Journal, Lancet, at that time no United
States federal money was even being expended to such an endeavor.41 Legal experts
have noted that such a ban raises many novel constitutional questions that need to
be addressed with respect to the First, Fifth, and Fourteenth amendments as well as
the interstate commerce clause.42
Despite the outcome of these Constitutional inquiries, it must be noted that the
role of the U.S. government in funding scientific projects has been on the decline
for many years, and one must question the effect of such a ban.43 While the federal
government continues to play a major role in its own laboratories and academic
research, industry now outspends the U.S. Treasury by a ratio of approximately two
to one.4 Moreover, many note that if a market for human cloning develops, despite
"presidential grandstanding" and legislative enactments, people will be able to work
around such rules.45
B. Who Would Hold the Property Rights Over Cloning Material?
In 1992, a team of scientists from George Washington University successfully
completed what is now known as "blastomere separation. ' 46 In that experiment,
polyploid embryos (embryos rendered non-viable due to the fact that they were
fertilized by more than one sperm) at the two to eight cell stage of development
were separated into single-celled organisms.4 Much like the situation regarding
embryos created via blastomere separation, the legal community is puzzled by how
cloning material should be classified 8
41. Daniel S. Greenberg, Much Ado About Mutton?. LANCET, June 21, 1997, at 1850.
42. See Cloning Challenges Hearings, supra note 38 (stating that the constitutionality of a federal ban on
human cloning research would need to be assessed in light of federal jurisdiction over private research. Such
jurisdiction may be based on the Interstate Commerce Clause or the Fifth and Fourteenth Amendments of the United
States Constitution, yet such jurisdiction would likely be subjected to opposition, including First Amendment
freedom of inquiry claims).
43. See Greenberg, supra note 41, at 1850.
44. Id.
45. Id.
46. Mona S. Amer, Breaking the Mold: Human Embryo Cloning and Its Implications for a Right to
Individuality, 43 UCLA L. REV. 1659, 1659-60 (1996).
47. Id. at 1664.
48. Id. at 1660.
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With respect to IVF, courts generally consider the created embryos to be the
property of the parents of that embryo.49 Yet, the notion that children produced by
a successful IVF procedure should themselves have property rights over the re-
maining embryos has not been tested in a court of law.5" This question arises
because if a remaining embryo was allowed to go to term, it would be a genetic
copy, much like the cloning procedure, of the initial successful embryo. 51 Normally
an individual possesses the DNA in his body, which is a unique entity of that
individual and under their personal control.52 One state, Louisiana, has remedied
this legal difficulty by classifying embryos created via IVF technology not as
property, but as judicial persons until they are implanted, and prohibits intentional
destruction of a viable embryo.53
C. Current Forensic Techniques May Become Obsolete
In arguably one of the most fascinating aspects of human cloning, it has been
noted that the current forensic method of DNA identification may be ruined by the
cloning breakthrough. The DNA identification procedure currently operates on the
notion that every individual's genetic makeup is unique and reliable in terms of
determining who matches a given biological sample. Clones, as mentioned pre-
viously, will possess genetically identical material and render the procedure much
less valuable.55
VI. CALIFORNIA LEGISLATION DIRECTED TOWARD HUMAN CLONING
Within two weeks of the announcement of Dolly's existence, a bill was intro-
duced in the California legislature that addressed the human cloning situation.56 It
was observed that existing law did not address the notion of human cloning.5
Existing law covered only the act of knowingly using ova, sperm, or embryos in
reproduction technology against the wishes indicated by the provider of that ova,
sperm, or embryo.58 Existing law also prohibited the implantation of ova, sperm, or
embryos via reproductive technology into a recipient who was not the provider of
the implant material without having received the written consent of both the pro-
49. Id. at 1661.
50. Id.
51. 1,.
52. Id. at 1668.
53. LA. REV. STAT. ANN. §§ 9:123, 9:129 (West 1991).
54. Roundtable Discussion, The Clone Age, 83 A.B.A.J. 68, 71 (1997).
55. Id.
56. SB 1344 (listing its introduction date as March II, 1997).
57. ASSEMBLY FLOOR, COMMrrrEEANALtStS OFAB 1251, at 2 (July 8, 1997).
58. CAL. PENAL CODE§ 367g(a) (West 1938 & Supp. 1998).
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vider and the recipient.5 9 Violation of those laws was punishable by either a fine not
to exceed $50,000, imprisonment from three to five years, or both a fine and
imprisonment.' In addition, unprofessional conduct complaints by either physicians
or surgeons resulted in the matter being initially heard by the Medical Board which
has the ability to revoke a doctor's certificate, prohibit or suspend a doctor from
practicing medicine, place that person on probation, reprimand publicly, or take any
other action necessary to discipline the individual. 61 The Division of Medical
Quality of the Medical Board, an Administrative Law Judge, or the local District
Attorney may also hear violations and pursue them as they see fit.62
A. Chapter 688
Chapter 688 defines "clone" as the practice of:
Creating or attempting to create a human being by transferring the nucleus
from a human cell from whatever source into a human egg cell from which
the nucleus has been removed for the purpose of, or to implant, the
resulting product to initiate a pregnancy that could result in the birth of a
human being.
63
This definition may not be entirely effective because technology may advance to
a point where the "implantation" of the product is not necessary-effectually it will
be ex vivo production of a viable embryo, and thus would render this definition too
narrow to prohibit the conduct it intends to prohibit.
64
Chapter 688 states that its intent is to prohibit the cloning of an entire human
being for a period of five years.65 This chapter will expire on January 1,2003, which
will allow the legislature to then review, update, and amend the provisions as
deemed necessary at that time.6 This chapter does not hinder cloning of human
cells, tissue, or organs, but instead only applies to the cloning of an entire human.67
During the five year period, Chapter 688 states that a panel of medical, religious,
biotechnology and genetics representatives will be established to review the cloning
situation and will then advise the Legislature and Governor regarding their
findings.68
59. Id. § 367g(b) (West 1988 & Supp. 1998).
60. Id. § 367g(c) (West 1988 & Supp. 1998).
61. CAL Bus. & PROF. CODE § 2227 (West 1990 & Supp. 1997).
62. Id.
63. CAL. HEALTH & SAFETY CODE § 24185(c) (added by Chapter 688).
64. Id.
65. 1997 Cal. Stat. ch. 668, sec. 1.
66. CAL. BUS. & PROF. CODE § 2260.5(b) (added by Chapter 688).
67. 1997 Cal. Stat. ch. 668. sec. 1.
68. Id.
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Chapter 688 states that if the cloning prohibition is violated, penalties of bet-
ween $250,000 and $1 million will be levied.69 Further, if the violator derives
pecuniary gain from his conduct, he may be assessed a civil penalty up to twice the
amount of the pecuniary gain, all monies being paid to the General Fund.70
B. Gaps in Chapter 688
Though Chapter 688 attempts valiantly to address the human cloning situation,
it leaves crucial gaps that may be exploited to the detriment of the State of
California. For example, Chapter 688's fines may prove to be entirely too small if
there indeed develops a market for cloned humans. It is entirely possible that even
Chapter 688's highest penalty of twice the pecuniary gain from the endeavor would
be but a fraction of the monetary gain incurred via successful cloning in that there
is ambiguity as to how that amount will be determined. For example, if one was
paid $10,000 to clone a human, the penalty would be $20,000. Yet, the one who
completed the cloning procedure may then receive endorsement contracts or other
types of compensation that are not directly related to the single cloning procedure
which may greatly exceed the $20,000 fine. In that case, one may consider violating
the law, recognizing that later compensation would eclipse the fine imposed.
In addition, the creation of Dolly by the Scottish researchers was preceded by
276 unsuccessful attempts.71 Chapter 688 does not address what is to be done with
such unsuccessful attempts. Another ambiguity in Chapter 688 is its definition of
"clone" which describes an activity that "could result in the birth of a human
being., 72 If a researcher could produce clones that fell short of satisfying Chapter
688's definition of human being (say, by not having reproduced all of the physical
and mental attributes of the human cloned), that researcher may be able to argue
that Chapter 688 was indeed not violated.
VII. CONCLUSION
The successful cloning of the sheep Dolly from the udder cell of an adult ewe
catapulted the world into the reality of human cloning possibility.73 Such a scientific
breakthrough carries with it tremendous promise, and at the same time tremendous
moral, religious, ethical, and legal questions.7 4 As a nation we must decide if and
how to proceed with cloning technology. More importantly, we must decide what
exactly to proceed with. Cloning of human DNA in order to more easily manipulate
69. CAL. HEALTH & SAFETY CODE § 2413.7(a)(b) (added by Chapter 688).
70. Id. § 24187(c)-(d) (added by Chapter 688).
71. See Wilmut, supra note 2, at 810.
72. CAL. HEALTH & SAFETY CODE § 2418 (added by Chapter 688).
73. See supra note 2 and accompanying text.
74. See supra notes 3, 4 and accompanying text.
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genes, replace diseased tissue, and conduct vital research has not been affected by
Chapter 688. However, as with most areas of law, it may not always be easy to
determine the bright line that distinguishes when Chapter 688 has been breeched.
As advances occur in prenatal medicine and neonatal care, the need for a uterus (the
"implantation" phase of Chapter 688) drops drastically and comes closer to ren-
dering the chapter less efficient. The cloning breakthrough is an unprecedented
intersection of science, morality, and law. The five year moratorium on human
cloning is designed to allow such morality and law to catch-up with the scientific
breakthrough and is essential to proceeding with this technology responsibly.

